NASDAQ · Medical - Devices

Pacific Biosciences of California, Inc. (PACB) Stock

$2.33 +1.30% NASDAQ: PACB Healthcare

Valuation

MetricValue
Price$2.33
Market Cap$723.70M
P/E Ratio-5.35
P/B Ratio-21.51
P/S Ratio4.49
EPS (TTM)$-1.82
52-Week High$3.44
52-Week Low$1.07
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-10920.00%
ROA-17.48%
ROCE-23.80%
Gross Margin-348.75%
Operating Margin-348.75%
Net Margin-82.49%
Debt/Equity-21.26
Current Ratio6.94

Annual Financials (USD)

Metric20212022202320242025
Revenue$131.0M$128.0M$201.0M$154.0M$160.0M
Operating Profit$-210.0M$-307.0M$-334.0M$-474.0M$-558.0M
Net Profit$-181.0M$-314.0M$-307.0M$-310.0M$-546.0M
EPS$-0.89$-1.40$-1.21$-1.07$-1.82
Op Margin-161.2%-239.4%-166.8%-308.0%-348.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.0B$1.8B$1.7B$1.3B$784.0M
Total Liabilities$1.2B$1.2B$1.0B$754.0M$779.0M
Cash$461.0M$325.0M$180.0M$55.0M$64.0M
Borrowings$955.0M$948.0M$934.0M$672.0M$760.0M

Latest News

Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market Zacks · Jul 20, 2026 1 Small-Cap Stock Worth Investigating and 2 That Underwhelm StockStory · Jul 17, 2026 PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026 GlobeNewswire · Jul 15, 2026 Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know Zacks · Jul 13, 2026 Here's Why You Should Add PacBio Stock to Your Portfolio Now Zacks · Jul 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-111.0M$-263.0M$-267.0M$-206.0M$-111.0M
Investing Cash Flow$-684.0M$99.0M$-4.0M$118.0M$113.0M
Financing Cash Flow$-20.0M$0$-86.0M$0$0
Net Cash Flow$380.0M$-138.0M$-145.0M$-124.0M$8.0M
Free Cash Flow$-117.0M$-280.0M$-275.0M$-212.0M$-114.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.08
EV / EBITDA-12.46
FCF Yield-23.96%
Quick Ratio4.03
Interest Coverage-42.23
Return 1Y-17.16%
Return 3Y-89.14%
Return 5Y-94.44%

Ownership

Insiders Held8.77%
Institutions Held53.81%
Institutions Float Held58.99%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc. is led by CEO Christian O. Henry, employs 575 people, headquartered in US, publicly traded since 2010.

Pacific Biosciences of California, Inc. (PACB) stock trades at $2.33 with a market capitalization of $723.70M. The stock is valued at a price-to-earnings (P/E) ratio of -5.35, price-to-book of -21.51, price-to-sales of 4.49. Over the past 52 weeks the stock has ranged between $1.07 and $3.44, and currently trades 32.3% below its 52-week high.

On profitability, Pacific Biosciences of California, Inc. generates a return on equity (ROE) of -10920.00%, return on capital employed of -23.80%, an operating margin of -348.75%, a net profit margin of -82.49%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides